- § 360aa. Recommendations for investigations of drugs for rare diseases or conditions
- § 360bb. Designation of drugs for rare diseases or conditions
- § 360cc. Protection for drugs for rare diseases or conditions
- § 360dd. Open protocols for investigations of drugs for rare diseases or conditions
- § 360ee. Grants and contracts for development of drugs for rare diseases and conditions
- § 360ee–1. FDA rare neurodegenerative disease grant program
- § 360ff. Priority review to encourage treatments for rare pediatric diseases
- § 360ff–1. Targeted drugs for rare diseases
Quick search by citation: